UNSPSC 51292205: Mosapride

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I8MFJ1C0BY. European Medicines Agency schedules Mosapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09074MIG. Mosapride generally arises in the molecular formula C21H25CLFN3O3.

UNSPSC 51292205 Mosapride is a Commodity code that does not align with recent state and local procurement activity. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives for direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which concern mosapride, an antiemetic medication used in clinical settings. The code's nominal scope and the work actually being solicited diverge materially, suggesting a cataloging mismatch rather than active procurement demand for mosapride itself in the state and local market.

The recent opportunities show activity from a Florida county health department (Seminole County), a state health and human services commission (Texas), and a multistate cooperative purchasing alliance (MMCAP, administered by Minnesota), but none of these solicitations target mosapride or related pharmaceutical compounds by name. Seminole County's IFB60459723LAS (due July 26, 2023, though posted June 30, 2026) sought naloxone and drug deactivation systems; Texas HHS issued an RFI on April 3, 2026, exploring vendor capacity for direct-to-manufacturer prescription programs; and MMCAP released an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code shows little relevant recent activity and does not reflect actual state and local procurement demand for mosapride.